Additional studies focusing on a subset of potential N-glycan protein targets demonstrated that low GCNT2/I-branched glycan expression increased melanoma cell proliferation and survival by enhancing IGF1R- and integrin:ECM-mediated signaling. This evidence concerns the gene IGF1R and melanoma.